title: Yet again no benefit of stenting over medical therapy.
authors.affiliation: Department of Neurology, Medical University of South Carolina Stroke Program, 19 Hagood Ave, Suite 501, Charleston, SC 29425, USA.
authors.forename: Tanya N
authors.initials: TN
authors.lastname: Turan
authors.affiliation: Department of Neurology, Medical University of South Carolina Stroke Program, 19 Hagood Ave, Suite 501, Charleston, SC 29425, USA. Electronic address: mchimow@musc.edu.
authors.forename: Marc I
authors.initials: MI
authors.lastname: Chimowitz
mesh_terms: D057510:Endovascular Procedures / Q000379:methods*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D002546:Ischemic Attack, Transient / Q000209:etiology*; D008297:Male; D011183:Postoperative Complications; D015607:Stents; D020521:Stroke / Q000209:etiology*; D014715:Vertebrobasilar Insufficiency / Q000188:drug therapy* / Q000601:surgery*
chemical_list: D005343:Fibrinolytic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors